Last edition
News about "cell therapy manufacturing "
Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies
Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.
Cell Therapy Manufacturing | 08/06/2026 | By News Bureau | 121
Cellares Moves Cell Therapy Manufacturing from Platform to Patients
The cell and gene therapy (CGT) sector is entering a phase of more disciplined and sustainable growth after years of volatility, according to industry leaders speaking at the 2026 Biotech Showcase in San Francisco.
Cell Therapy Manufacturing | 29/01/2026 | By Darshana | 221
Lonza Expands TheraPEAK Product Portfolio, Launches AmpliCell Cytokines and TheraPEAK 293-GT Medium
Switzerland-based Lonza has expanded its GMP solutions for cell and gene therapy with the launch of TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium.
Cell Therapy Manufacturing | 07/10/2025 | By Dineshwori | 267
Limula Rolls Out LimONE for Seamless Workflow in Cell Therapy Manufacturing
LimONE is designed for both hospitals and biopharma companies alike, providing a versatile tool that supports the production of multiple types of cell therapy, including CAR-T and gene-edited hematopoietic stem cells.
Cell Therapy Manufacturing | 07/03/2025 | By Aishwarya | 593
Champalimaud Foundation to Leverage Lonza Platform to Advance Cell Therapy
Champalimaud Foundation, a biomedical clinical research organization carrying out research and cutting-edge clinical development and discoveries that benefit people, and Lonza have announced the installation of Lonza’s MODA-ES Platform at the Champalimaud Clinical Centre in Lisbon, Portugal.
Cell Therapy Manufacturing | 13/08/2024 | By Aishwarya | 880
Limula Secures USD 6.8 Million in Oversubscribed Seed Round
Limula has raised USD 6.8 million to take their solution for automating cell therapy manufacturing to the next stage of development.
Cell Therapy Manufacturing | 22/05/2024 | By Aishwarya | 377
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy